Eko, a San Francisco, CA-based AI-powered digital health company, closed $20M Series B funding.
The round was led by Artis Ventures with participation from DigiTx Partners, NTT Venture Capital (NTTVC), 3M Ventures, Mayo Clinic, Seraph Group, and XTX Ventures.
The company intends to use the funds to drive further research and commercialization of its machine learning platform.
Founded in 2013 by Connor Landgraf, Jason Bellet, and Tyler Crouch, Eko is a digital health company building machine learning tools to fight heart disease. Its cardiac monitor combines digital stethoscope and ECG technology both for in-clinic and at-home monitoring, which enables patients to send cardiac data to their physicians. The company is collaborating with medical device and pharmaceutical companies to create combinations of therapies and data to help personalize cardiac care.
Eko will also grow its focus on clinical research, investing more in its collaborations with the Mayo Clinic, Northwestern Medicine, and UCSF. Expanding its collaborative studies will enable the company to build algorithms with robust datasets targeted to specific conditions, including atrial fibrillation and valvular heart disease, as well as congestive heart failure and structural heart disease.